Log in to your Inderes Free account to see all free content on this page.
Alligator Bioscience
1.36 SEK -0.73%3 investors are following this company
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
ATORX
Daily low / high price
1.324 / 1.394
SEK
Market cap
1.03B SEK
Turnover
1.78M SEK
Volume
1.3M
Latest videos
Financial calendar
Interim report
24.10.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Allegro Investment | 32.9 % | 33.0 % |
Roxette Photo | 7.0 % | 7.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Alligator Bioscience AB reports financial results for H1 2024 and Q2 2024 and provides a business update
Alligator Bioscience Announces Completion of Enrollment in Mitazalimab OPTIMIZE-1 Study
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio